2 results
Approved WMOCompleted
The objective of the study is to assess the safety, tolerability and efficacy of PRO044.
Approved WMOCompleted
To demonstrate the additive IOP lowering effect of SIMBRINZA (dosed BID) when added to DUOTRAV solution in subjects with open-angle glaucoma or ocular hypertension.